Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy

Por Hsu, Ching-Sheng, Hsu, Shih-Jer, Liu, Wei-Liang, Chen, Ding-Shinn, Kao, Jia-Horng
Publicado no Sci Rep (2016)

High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments

Por Nien, Hsiao-Ching, Hsu, Shih-Jer, Su, Tung-Hung, Yang, Po-Jen, Sheu, Jin-Chuan, Wang, Jin-Town, Chow, Lu-Ping, Chen, Chi-Ling, Kao, Jia-Horng, Yang, Wei-Shiung
Publicado no PLoS One (2017)

Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy

Por Hsu, Ching-Sheng, Hsu, Shih-Jer, Chen, Hung-Chia, Tseng, Tai-Chung, Liu, Chen-Hua, Niu, Wei-Fang, Jeng, Jenher, Liu, Chun-Jen, Lai, Ming-Yang, Chen, Pei-Jer, Kao, Jia-Horng, Chen, Ding-Shinn
Publicado em 2011

Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients

Por Yang, Chi-Chieh, Tsai, Wei-Lun, Su, Wei-Wen, Huang, Chung-Feng, Cheng, Pin-Nan, Lo, Ching-Chu, Tseng, Kuo-Chih, Mo, Lein-Ray, Wang, Chun-Hsiang, Hsu, Shih-Jer, Lai, Hsueh-Chou, Su, Chien-Wei, Liu, Chun-Jen, Peng, Cheng-Yuan, Yu, Ming-Lung
Publicado no PLoS One (2015)

Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients

Por Lee, Mei-Hsuan, Huang, Chung-Feng, Lai, Hsueh-Chou, Lin, Chun-Yen, Dai, Chia-Yen, Liu, Chun-Jen, Wang, Jing-Houng, Huang, Jee-Fu, Su, Wen-Pang, Yang, Hung-Chih, Kee, Kwong-Ming, Yeh, Ming-Lun, Chuang, Po-Heng, Hsu, Shih-Jer, Huang, Ching-I, Kao, Jung-Ta, Chen, Chieh-Chang, Chen, Sheng-Hung, Jeng, Wen-Juei, Yang, Hwai-I, Yuan, Yong, Lu, Sheng-Nan, Sheen, I-Shyan, Liu, Chen-Hua, Peng, Cheng-Yuan, Kao, Jia-Horng, Yu, Ming-Lung, Chuang, Wan-Long, Chen, Chien-Jen
Publicado no Sci Rep (2017)